Pricing Log in Create free account

Satellos Bioscience Inc. (MSLE) vs Tiziana Life Sciences Ltd (TLSA)

Satellos Bioscience Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. Satellos Bioscience Inc. and Tiziana Life Sciences Ltd are of similar size ($145.1M and $134.7M). Across the 7 metrics below, Tiziana Life Sciences Ltd leads on 4 and Satellos Bioscience Inc. on 3.

Valuation

Metric MSLE TLSA Biotechnology median
P/E n/m n/m 8.42
P/S n/m n/m 10.01
P/B 2.38 n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m 0.04 0.61
EV/Sales n/m n/m 9.41
Earnings yield (28.07%) (50.37%) (31.85%)
Free cash flow yield (20.36%) 0.00% (24.58%)

Profitability

Metric MSLE TLSA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (70.45%) 0.00% (56.36%)
Return on assets (64.76%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MSLE TLSA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 21.20% (45.45%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MSLE TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 0.76 4.72
Net debt to EBITDA 1.05 0.19 0.96

Dividend

Metric MSLE TLSA Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric MSLE TLSA Biotechnology median
Market cap 145.14m 134.73m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack